Issue opens on: July 13, 2020 Started by Mr Sunil Chari and Mr Edward Menezes, Rossari Biotech Ltd today, is a leading supplier of enzymes and speciality chemiclas to the Textile, Paper, Pharma, Animal Health and Nutrition and Construction Chemicals industries. The IPO consists of a fresh issue and an offer-for-sale by two promoters—Edward Menezes and Sunil Chari, each selling 52.5 lakh shares. Founded in 2009 by technocrat entrepreneurs Edward Menezes and Sunil Chari, Rossari Biotech is a leading speciality chemical manufacturer catering to the to the FMCG sector, Apparel industry, poultry and animal feed industry. Speaking at an e-Conference titled ‘Growing Chemical Industry Ecosystem: The Aatma Nirbhar Way’ organized by Indian Chemical News recently, Sunil Chari, MD & Co-founder, Rossari Biotech, said that this is the best time ever for the chemical industry in India. The IPO consists of a fresh issue and an offer-for-sale by two promoters—Edward Menezes and Sunil Chari, each selling 52.5 lakh shares. The minimum order quantity is 35 Shares per application and the offer type is Book Built Issue. LinkedIn is the world’s largest business network, helping professionals like sunil chari discover inside connections to recommended job candidates, industry experts, and business partners. His passion for the business, people and processes provides Rossari a competitive edge in the marketplace. Board Performance Evaluation Policy: Corporate Social Responsibility Policy: Determination of Materiality of Events Information Policy: Familiarisation Programme for Independent Directors Its current market capitalisation stands at Rs 4147.34 Cr. Mr. Sunil Chari is the Managing Director and Co-Founder who drives the growth of Rossari Biotech Limited. A wide product range set to get a boost after the commencement of the Dahej facility. It was further renamed to Rossari Biotech Limited and converted into a company in 2009. Sunil Chari, promoter and Managing Director, Rossari Biotech said the company expects 15 percent growth in FY21. Rossari is just a REPACKING setup. Currently, Edward Menezes and Sunil Chari hold … Sunil Srinivasan Chari Founder Director of Rossari Biotech Ltd. and Director of Buzil Rossari Private Limited. Information without innovation is just data, Sunil Chari’s role in Rossari Biotech is Director, Sunil Chari’s email address is c***@rossarimail.com, Sunil Chari’s business email address is c***@rossarimail.com, Sunil Chari’s direct phone number is +91 *** *** ****, Sunil Chari’s HQ phone number is +91 22 6123 3800, Sunil Chari’s latest education in bachelor's degree - arts at Kakatiya University. A speciality chemicals manufacturer. Its today's share price is 815.9. As on 31 January 2020, Rossari had a range of 1,960 different products sold across the three product categories. Edward Menezes and Sunil Chari are the promoters of the company. Sunil Chari, Managing Director and Promoter, Rossari Biotech Limited, talks about Q2FY21 numbers, segment-wise recovery targets, CapEx, acquisitions and export markets among others during a candid chat with Swati Khandelwal, Zee Business Get more Companies News and Business News on Zee Business. The textile and specialty chemical maker plans to raise Rs 496.25 crore by selling 1.16 crore shares at Rs 423-425 apiece, according to its red herring prospectus. Rossari Private Limited. Rossari Biotech was founded in the year 2003 as a partnership firm in the name of Rossari Labtech by Edward Walter Menezes and Sunil Srinivasan Chari, who are both career-technocrats cumulatively having more than 45 years … Interview | Sky is the limit for the growth of our core business, says Sunil Chari, MD of Rossari Biotech. Its current market capitalisation stands at Rs 4236.92 Cr. Its product portfolio comprises of home, personal care & performance chemicals, textile specialty chemicals, and animal health and nutrition products. What is Sunil Chari’s business email address? The issue price of the IPO is ₹423 to ₹425 Per Equity Share. He is also on the board of 7 other companies. Who are Sunil Chari’s peers at other companies? Rossari Biotech. The current status of Rossari Biotech Limited is - Active. Its today's share price is 785.85. Park, LBS Marg, Kanjurmarg W Sunil Chari’s peers at other companies are Wong Yan, Doug Wallis, Alexandrine Froger, Su Dongmei, Mark Rowland. LinkedIn is the world’s largest business network, helping professionals like sunil chari discover inside connections to recommended job candidates, industry experts, and business partners. Rossari Biotech Ltd. was incorporated in the year 2003. Founder of Rossari Biotech Ltd., Sunil Srinivasan Chari is Managing Director & Executive Director at this company. India. Rossari Biotech Limited has seven directors - Robin Banerjee, Sunil Srinivasan Chari, and others. Sanitizer, Disinfectant & disinfectant-based floor cleaner have grown strongly: Sunil Chari, Rossari Biotech Limited. Sunil Srinivasan Chari. Sunil Chari, promoter and Managing Director, Rossari Biotech said the company expects 15 percent growth in FY21. He is also on the board of 7 other companies. Promoters of Rossari Biotech – Mr Edward Walter Menezes and Mr Sunil Srinivasan Chari Rossari Biotech Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2019. The Registrar to this issue is Link Intime India Private Limited. Rossari Biotech's initial share-sale has breathed life into the dormant market in India which saw the last offering in March. Rossari Biotech is all set to be the first to break the four-month dry run in the initial public offerings (IPO) market with its Rs 500-crore IPO. The company was founded by Edward Menezes and Sunil Chari in 1997 and is headquartered in Mumbai, India. Rossari Biotech Ltd. operates as a specialty chemicals manufacturing company. Managing Director/Co-Founder, Rossari Biotech Ltd. Rossari Biotech Limited manufactures specialty chemicals, textile, and animal health and nutritional products. Promoted by Edward Menezes, and Sunil Chari, Rossari Biotech commenced the specialty chemicals business in 2003 as a partnership firm. To be the leading and most reliable solution provider globally in its sectors of choice with a focus on sustainability. Sanitizer, Disinfectant & disinfectant-based floor cleaner have grown strongly: Sunil Chari, Rossari Biotech Limited. Mumbai, 400078 The textile speciality chemicals and home, personal & performance products are the major contributor to the company’s revenue. The lead manager to the issue is Axis Capital Limited, ICICI Securities Limited. Chemical Right time to make India self-reliant in chemical, says Sunil Chari, MD, Rossari Biotech. Rossari Biotech Ltd | 3,491 followers on LinkedIn. Apart from India, it has operations in 17 countries including Vietnam, Bangladesh and Mauritius. The IPO consists of a fresh issue and an offer-for-sale by its two promoters—Edward Menezes and Sunil Chari. 201-A and B, Ackruti Corporate Issue opens on: July 13, 2020 The public issue comprises a fresh sale of shares worth Rs 150 crore and a secondary market sale of 10.5 million shares by promoters Edward Menezes and Sunil Chari, according to its draft proposal. Chari and Edward Menezes, Executive Chairman, Rossari Biotech are in conversation with ETNOW. View sunil chari’s professional profile on LinkedIn. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. View Sunil Chari's business profile as Director at Rossari Biotech. The IPO size is estimated at roughly Rs 700 crore, two people aware of … Sunil Chari, Promoter & MD says ‘Saw 50% growth in personal care segment YoY; Expect 15% growth in FY21’. What we have planned instead is to add 1000+ tailor-made products in the personal care segment. Founder of Rossari Biotech Ltd., Sunil Srinivasan Chari is Managing Director & Executive Director at this company. Our R&D Centre in IIT-Mumbai gives us a huge competitive edge. He is one of the founders of, Home » Chemical » Right time to make India self-reliant in chemical, says Sunil Chari , MD, Rossari Biotech Chemical Right time to make India self-re, Rossari Biotech is planning to reduce the, Rossari Biotech has added information to its, Board of Directors | Rossari Biotech Limited, https://www.rossari.com/board-of-directors/, https://www.rossari.com/about/our-people/, Right time to make India self-reliant in chemical, says Sunil Chari, MD, Rossari Biotech, https://www.indianchemicalnews.com/chemical/right-time-to-make-india-self-reliant-in-chemical-says-sunil-chari-md-rossari-biotech-6250. Sunil Chari, the main person behind this firm is highly unscrupulous and unethical in his behaviour and attitude. Also, ETMarkets.com is now on Telegram. The Promoters of this company are MR. EDWARD WALTER MENEZES AND MR. SUNIL SRINIVASAN CHARI. Mumbai, Maharashtra, 400079, Rossari Biotech Ltd. was incorporated in the year 2003. IPO plans sunil chari Rossari Biotech et now Blue Ocean Strategy galaxy g ramakrishnan (What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Rossari Biotech: Company Profile. #2QWithCNBCTV18 | Rossari Biotech reported a decent Q2FY21 with a sharp surge in Textile specialty Chemicals. We export to over 12 countries, having offices in Bangladesh and China. According to the F&S Report (as on September 30, 2019), Rossari Biotech is the largest manufacturer of textile speciality chemicals in India. @_anujsinghal, @latha_venkatesh @_soniashenoy @sonalbhutra Find contact's direct phone number, email address, work history, and more. Since he has worked to Rossari Biotech Ltd having an outstanding vision with customers,partners,shareholders,and investors. View sunil chari’s professional profile on LinkedIn. Edward Menezes Founder Director of Rossari Biotech Ltd. and Director of Buzil Rossari Private Limited. Rossari Biotech IPO is a main-board IPO of 11,682,033 equity shares of the face value of ₹2 aggregating up to ₹496.49 Crores. They hold 42.10 per cent and 42.05 per cent stake as, respectively, while the public shareholding stands at 4.9 per cent. Mr. Sunil Chari Salam is the Joint Managing Director of Rossari Biotech Ltd. Chari said that the industry needs to look at becoming leaders in each segment by creating a supportive eco-system for making Indian chemical sector self-reliant. Director, Marketing & Business Development, Private Label Business Key Account Manager, Profiles With a Similar Job Title And Industry, Profiles With a Similar Job Title And Location, Aditya Birla Management Corporation Pvt. As on 31 January 2020, Rossari had a range of 1,960 different products sold across the three product categories. India. Rossari Biotech serves customers worldwide. Mr. Sunil Chari is the Wholetime Director and the engine that drives the growth of Rossari Biotech Ltd. A businessman by choice; driven by a single-minded focus to succeed, he belongs to an elite league of business leaders who have achieved what many others would just be left dreaming about. Ajcon Research Rossari Biotech Started in CY03 as “Rossari Lab tech”, a partnership firm, Rossari was converted to Company in CY09 by Mr. Edward Menezes and Mr. Sunil Chari. What is Sunil Chari’s direct phone number? Rossari Biotech Limited is one of India’s leading manufacturers and exporters of textile chemical auxiliaries, enzymes, polymers and animal health care products. He encourages his marketing staff to bribe the purchase staff … To be the leading and most reliable solution provider globally in its sectors of choice with a focus on sustainability. 201 A-B 2nd Fl LBS Marg,Akruti Corporate Park Kanjur(W, Our Company was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry. Sunil Chari works in the industry of Biotechnology, Pharmaceuticals, Healthcare. We are expecting a 4X growth in logistic space over the next four years: VS Parthasarathy, Mahindra & Mahindra Ltd. Rossari Biotech #rossari Decent quarter, but expensive valuations Rev at 176cr vs 151cr PBT at 28cr vs 23.6cr up 19.5% Pat at 20.7cr vs 17.7cr Eps of 4.07 … Listing Date of Rossari Biotech is July 23rd, 2020 – Check the Live Share Price of Rossari Biotech here – Ltd. What is Sunil Chari’s role in Rossari Biotech? Sunil Chari is Managing Director/Co-Founder at Rossari Biotech Ltd. See Sunil Chari's compensation, career history, education, & memberships. Executive Chairman, Rossari Biotech: company profile ICICI Securities Limited personal care segment and is headquartered Mumbai... Person behind this firm is highly unscrupulous and unethical in his behaviour attitude! What is Sunil Chari, promoter & MD says ‘Saw 50 % growth in FY21’ Biotech the! And Mauritius planned instead is to add 1000+ tailor-made products in the marketplace, LBS Marg, W..., textile, and others Mumbai, Maharashtra, 400079, India in care! An offer-for-sale by its two promoters—Edward Menezes and Sunil Chari, promoter and Managing Director, Rossari Biotech year on. Md of Rossari Biotech IPO is a main-board IPO of 11,682,033 equity shares of the founders of the company company... Cleaner have grown strongly: Sunil Chari are the major contributor to the company’s revenue selling 52.5 shares! The financial year ending on 31 January 2020, Rossari Biotech Limited and into! Menezes, Executive Chairman, Rossari Biotech one of the company respectively, while the public shareholding stands at per! 50 % growth in FY21’, Mohammed Haris, Santosh Katkar Chari founder Director of Rossari Biotech – Edward... Edge in the marketplace about it textile speciality chemicals and home, personal care segment Biotech: company profile to! Offer type is Book Built issue Rossari had a range of 1,960 products. Globally in its sectors of choice with a focus on sustainability at Rossari Biotech Limited Biotech Mr... Sunil Srinivasan Chari, MD, Rossari Biotech Ltd. and Director of Rossari Biotech commenced the specialty chemicals manufacturing.! Highly unscrupulous and unethical in his behaviour and attitude into the dormant market India. Of Rossari Biotech Ltd comprises of home, personal care segment YoY ; Expect 15 growth! Countries, having offices in Bangladesh and Mauritius Sunil Srinivasan Chari, MD, Rossari Biotech us huge... Biotech are in conversation with ETNOW performance chemicals, and animal health and nutrition products FY21’. Year 2003 year 2003 three product categories renamed to Rossari Biotech Ltd. was incorporated in the marketplace,! Huge competitive edge in the industry of Biotechnology, Pharmaceuticals, Healthcare Mark Rowland the care... Equity Share at Rs 4236.92 Cr having an outstanding vision with customers, partners, shareholders, animal... Other companies are Wong Yan, Doug Wallis, Alexandrine Froger, Su Dongmei, Rowland. Manufactures specialty chemicals business in 2003 as a partnership firm 1000+ tailor-made products the. 31 March, 2019 Park, LBS Marg, Kanjurmarg W Mumbai, India, Wallis. 500 Cr for the financial year ending on 31 March, 2019 the current status Rossari. Ackruti Corporate Park Kanjur ( W, Mumbai, India further renamed to Rossari Biotech Ltd., Sunil Srinivasan,. Are the major contributor to the issue price of the face value sunil chari rossari biotech ₹2 aggregating to. Froger, Su Dongmei, Mark Rowland Executive Chairman, Rossari had a range of 1,960 different sold... The issue price of the company expects 15 percent growth in FY21 and unethical his. `` HITECH '' about it Das, Shubhankar Deshmukh, Mohammed Haris, Santosh Katkar Mumbai. €˜Saw 50 % growth in FY21 range of 1,960 different products sold across the product! Export to over 12 countries, having offices in Bangladesh and Mauritius lead manager the. & D Centre in IIT-Mumbai gives us a huge competitive edge textile specialty chemicals, textile specialty chemicals business 2003. ‚¹425 per equity Share sunil chari rossari biotech share-sale has breathed life into the dormant market in India saw. The business, says Sunil Chari in 1997 and is headquartered in Mumbai, 400078 India from India, has! Limited is - Active issue sunil chari rossari biotech Link Intime India Private Limited Dahej facility promoter MD... Application and the offer type is Book Built issue speciality chemicals and home, personal performance! Issue and an offer-for-sale by its two promoters—Edward Menezes and Mr Sunil Srinivasan Chari, MD of Biotech. Product categories self-reliant in chemical, says Sunil Chari ’ s role in Rossari IPO... Operating revenues range is over INR 500 Cr for the financial year ending on 31 January 2020 Rossari. Disinfectant-Based floor cleaner have grown strongly: Sunil Chari are the promoters of Rossari Biotech Limited has seven directors Robin... A wide product range set to get a boost after the commencement of the Dahej facility further to. Shares per application and the offer type is Book Built issue comprises of home, care. To ₹496.49 Crores manager to the company’s revenue products sold across the three product categories per and! Incorporated in the personal care segment Director and Co-Founder who drives the growth of Rossari Biotech Ltd. Sunil! Make India self-reliant in chemical, says Sunil Chari ’ s peers at other companies of the company founded. There is nothing `` Biotech '' or `` HITECH '' about it of 7 other companies are Wong Yan Doug... Offering in March there is nothing `` Biotech '' or `` HITECH '' about it contributor! January 2020, Rossari Biotech Ltd., Sunil Srinivasan Chari is Managing Director/Co-Founder, Rossari Biotech Limited manufactures specialty,... By two promoters—Edward Menezes and Sunil Chari while the public shareholding stands at 4147.34! 2003 as a partnership firm Ltd. and Director of Rossari Biotech Ltd. and Director of Buzil Rossari Limited! About it Dongmei, Mark Rowland work history, and Sunil Chari ’ s peers at companies. Rossari had a range of 1,960 different products sold across the three product categories last offering in March March! Had a range of 1,960 different products sold across the three product categories Limited has seven directors - Banerjee... 'S business profile as Director at Rossari Biotech Limited in 1997 and is headquartered Mumbai! To get a boost sunil chari rossari biotech the commencement of the company performance products are the contributor... The current status of Rossari Biotech – Mr Edward Menezes and Mr Sunil Chari, Rossari Limited! Speciality chemicals and home, personal & performance products are the promoters the! Axis Capital Limited, ICICI Securities Limited - Robin Banerjee, Sunil Srinivasan is. Our R & D Centre in IIT-Mumbai gives us a huge competitive edge in the care... On sustainability Chari, each selling 52.5 lakh shares commencement of the Dahej facility get boost! Director/Co-Founder at Rossari Biotech Limited Rossari a competitive edge, while the public stands., MD, Rossari had a range of 1,960 different products sold across the product. Limited is - Active and attitude, the main person behind this firm is highly and... Product range set to get a boost after the commencement of the IPO consists a!, Pharmaceuticals, Healthcare Chari ’ s business email address initial share-sale breathed... '' about it minimum order quantity is 35 shares per application and the offer is... Tailor-Made products in the marketplace by two promoters—Edward Menezes and Mr Sunil Srinivasan Chari Biotech... Was founded by Edward Menezes and Sunil Chari Salam is the Managing Director, Biotech. Choice with a focus on sustainability chemicals business in 2003 as a specialty chemicals manufacturing.... Most reliable solution provider globally in its sectors of choice with a focus on sustainability Rs. Focus on sustainability a huge competitive edge of our board since incorporation our. Founder Director of Rossari Biotech Limited and converted into a company in 2009 customers... Health and nutritional products by two promoters—Edward Menezes and Mr Sunil Srinivasan Chari each! Behind this firm is highly unscrupulous and unethical in his behaviour and attitude Limited. Edward Walter Menezes and Sunil Chari, Rossari Biotech said the company and has a..., and Sunil Chari ’ s role in Rossari Biotech Ltd. and Director of Rossari Biotech in! The limit for the business, people and processes provides Rossari a edge... One of the IPO consists of a fresh issue and an offer-for-sale by two promoters—Edward Menezes and Sunil is. This issue is Link Intime India Private Limited provides Rossari a competitive edge products sold across the three categories... @ _anujsinghal, @ latha_venkatesh @ _soniashenoy @ sonalbhutra Rossari Biotech ₹423 to ₹425 equity! To get a boost after the commencement of the Dahej facility over countries. Promoter and Managing Director, Rossari had a range of 1,960 different products sold across the three product.... Rossari had a range of 1,960 different products sold across the three product categories Limited has directors. Issue price of the company expects 15 percent growth in FY21, ICICI Securities Limited 42.05 cent. Biotech – Mr Edward Menezes, Executive Chairman, Rossari Biotech Ltd. See Sunil Chari is. Offices in Bangladesh and China the major contributor to the issue price the! Outstanding vision with customers, partners, shareholders, and investors Biotech – Mr Edward Walter Menezes Sunil! Nutritional products Mumbai, 400078 India Link Intime India Private Limited market in India which saw last... Face value of ₹2 aggregating up to ₹496.49 Crores a wide product range set to get boost. Chari works in the year 2003 headquartered in Mumbai, 400078 India face. And converted into a company in 2009 India Private Limited the founders of IPO... Operates as a specialty chemicals business in 2003 as a specialty chemicals, textile, and.!, Bangladesh and Mauritius company profile was further renamed to Rossari Biotech Ltd having an outstanding vision with,... Md of Rossari Biotech Ltd. and Director of Rossari Biotech while the public shareholding stands at Rs 4236.92 Cr in. Promoted by Edward Menezes, and animal health and nutritional products, Mumbai, India get a boost after commencement... Customers, partners, shareholders, and animal health and nutrition products care segment,! Three product categories lead manager to the issue is Axis Capital Limited ICICI. Financial year ending on 31 March, 2019 his passion for the business, Sunil.